01 5Adcal-D3
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2020 Revenue in Millions : 30
2019 Revenue in Millions : 28
Growth (%) : 7
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2021 Revenue in Millions : 25
2020 Revenue in Millions : 30
Growth (%) : -6
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2022 Revenue in Millions : 23
2021 Revenue in Millions : 25
Growth (%) : -10
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2023 Revenue in Millions : 11
2022 Revenue in Millions : 23
Growth (%) : -43
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2019 Revenue in Millions : 28
2018 Revenue in Millions : 33
Growth (%) : -14
LOOKING FOR A SUPPLIER?